BOSTON THERAPEUTICS, INC.

Profile

Company Names

BOSTON THERAPEUTICS, INC.

Addresses

354 MERRIMACK STREET #4, LAWRENCE, MA 01843

354 MERRIMACK STREET, #4, LAWRENCE, MA 01843

1750 ELM STREET, MANCHESTER, NH 03104

33 SOUTH COMMERCIAL STREET, MANCHESTER, NH 03101

Phone Numbers

603-935-9799
978-886-0421

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS, OTHER

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$12,542,778.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-06-25 
$8,434,778.00 
$8,434,778.00 
$0.00 
Debt 
3
2016-08-12 
$1,600,000.00 
$2,000,000.00 
$400,000.00 
Debt 
2
2013-07-23 
$2,000,000.00 
$8,000,000.00 
$6,000,000.00 
Equity 
1
2011-06-21 
$508,000.00 
$508,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CONROY 
CHI-HENG 
CHENG 
DIRECTOR
BOSTON THERAPEUTICS, INC.
DALE 
H. 
CONAWAY 
DIRECTOR
BOSTON THERAPEUTICS, INC.   |  OXYGEN THERAPY, INC.
DALE 
 
CONWAY 
DIRECTOR
BOSTON THERAPEUTICS, INC.
ROM 
 
ELIAZ 
DIRECTOR
JJ PHARMA INC   |  BOSTON THERAPEUTICS, INC.   |  IR-MED, INC.
HENRY 
 
ESBER 
DIRECTOR
INNOVUS PHARMACEUTICALS, INC.   |  BOSTON THERAPEUTICS, INC.   |  GENERAL ONCOLOGY, INC.
ALAN 
 
HOBERMAN 
DIRECTOR
BOSTON THERAPEUTICS, INC.   |  OXYGEN THERAPY, INC.   |  BIOXYTRAN, INC
DAVID 
 
LUDVIGSON 
EXECUTIVE OFFICER, DIRECTOR
EPARK SYSTEMS, INC.   |  BOSTON THERAPEUTICS, INC.
CARL 
 
LUEDERS 
DIRECTOR
BOSTON THERAPEUTICS, INC.
COLIN 
 
NEILL 
DIRECTOR
BOSTON THERAPEUTICS, INC.
DAVID 
 
PLATT 
EXECUTIVE OFFICER, DIRECTOR
PLATTFORM BUILDING SYSTEMS, INC.   |  BOSTON THERAPEUTICS, INC.   |  OXYGEN THERAPY, INC.   |  BIOXYTRAN, INC   |  HUNGRY HARVEST, LLC   |  ACQUIRE TIMBER, LLC   |  ACQUIRE LAND CO, LLC
DAVID 
 
PLATT, PH. D. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BOSTON THERAPEUTICS, INC.
CARL 
W. 
RAUSCH 
EXECUTIVE OFFICER
BOSTON THERAPEUTICS, INC.
KENNETH 
 
TASSEY, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BOSTON THERAPEUTICS, INC.
KENNETH 
A. 
TASSEY, JR. 
EXECUTIVE OFFICER, DIRECTOR
BOSTON THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-07-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-06-25 
2016-09-20
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-08-12 
2016-08-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-08-12 
2013-08-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-07-23 
2011-07-05
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-06-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MAXIM GROUP, LLC
120708
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
NONE